Mucosal immune system in neonatal period and early infancy

Pediatric Health

Volumn 4, Issue 6, 2010, Pages 637-647

  Ogra, Pearay L ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b CHILDREN S HOSPITAL OF BUFFALO   (United States)

Author keywords

mucosal immunity; mucosal microflora; neonatal immunity; Peyers patch development

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR9; GAMMA INTERFERON; HLA DR ANTIGEN; IMMUNOGLOBULIN A; INHIBITOR OF DIFFERENTIATION 2; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 7 RECEPTOR; LIPOPOLYSACCHARIDE BINDING PROTEIN; MANNAN BINDING LECTIN; MANNOSE RECEPTOR; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN KINASE R; SCAVENGER RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; B LYMPHOCYTE; DENDRITIC CELL; HOST RESISTANCE; HUMAN; IMMUNOLOGICAL TOLERANCE; INFANCY; INNATE IMMUNITY; INTESTINE LYMPHATIC TISSUE; LYMPHOID TISSUE; MICROBIAL IMMUNITY; MICROFLORA; MUCOSAL IMMUNITY; NEWBORN PERIOD; NONHUMAN; PEYER PATCH; PLASMA CELL; POSTNATAL DEVELOPMENT; REVIEW; T LYMPHOCYTE;

EID: 78650507714     PISSN: 17455111     EISSN: None     Source Type: Journal    
DOI: 10.2217/phe.10.67     Document Type: Review

References (51)

1. Medzhitov R, Janeway C Jr: Innate immunity. N. Engl. J. Med. 343, 338-344 (2000).
2. Ogra PL, Welliver RC Sr: Effects of early environment on mucosal immunologic homeostasis, subsequent immune responses and disease outcome. In: The Window of Opportunity: Pre-Pregnancy to 24 Months of Age. Nestle Nutrition Workshop Ser Pediatr Program (Volume 6). Barker DJP, Bergmann RL, Ogra PL (Eds). Nestec Ltd, Vevey/S Karger AG, Basel, Switzerland, 145-181 (2008).
3. Levy O: Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7, 379 (2007).
4. Mezhitov R, Preston-Hurlburt P, Janeway CA: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397 (1997).
5. Liu YJ: IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Ann. Rev. Immunol. 23, 275-306 (2005).
6. Steinman RM, Hemmi H: Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 311, 17-58 (2006).
7. Worbs T, Forster R: A key role for CCR7 in establishing central and peripheral tolerance. Trends Immunol. 28, 274-280 (2007).
8. Worbs T, Bode U, Yan S et al.: Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J. Exp. Med. 203, 519-527 (2006).
9. Zaghouani H, Hoeman CM, Adkins B: Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol. 30, 585-591 (2009).
10. Chen CC, Louie S, McCormick BA et al.: Helminth-primed dendritic cells alter the host response to enteric bacterial infection. J. Immunol. 176, 472-483 (2006).
11. Thrane PS, Rognum TO, Brandtzaeg P: Ontogenesis of the secretory immune system and innate defense factors in human parotid glands. Clin. Exp. Immunol. 86, 342-348 (1991).
12. Dawarkada AM, Saha K, Mathur NB: A comparative study of cells and anti-microbial proteins in colostrums of mothers delivering pre- and full-term babies. J. Trop. Paediatr. 37, 214-219 (1991).
13. Joyner JL, Augustine NH, Taylor KA et al.: Effect of group B streptococci on cord and adult mononuclear cell interleukin-12 and interferon-g mRNA accumulation and protein secretion. J. Infect. Dis. 182, 974-977 (2000).
14. Espinola-Klein C, Rupprecht HJ, Blankenberg S et al.: Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 105, 15 (2002).
15. Michelsen KS, Doherty TM, Shah PK, Arditi M: TLR signaling: an emerging bridge from innate immunity to atherogenesis. J. Immunol. 173, 5901 (2004).
16. Gereda JE, leung DY, Thatayatikom A et al.: Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitization in infants at high risk of asthma. Lancet 355, 1680 (2000).
17. Kiechl S, Egger G, Mayr M et al.: Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 103, 1064 (2001).
18. Ku CL, Yang K, Bustamante J et al.: Inherited disorders of human Toll-like receptor signaling: immunological implications. Immunol. Rev. 203, 10 (2005).
19. Von Bernuth H, Picard C, Jin Z et al.: Pyogennic bacterial infections in humans with MyD88 deficiency. Science 321, 691 (2008).
20. Thibeault SL, Rees L, Pazmany L, Birchall MA: At the crossroads: mucosal immunology of the larynx. Mucosal Immunol. 2, 122-128 (2009).
21. Ogra PL: Ageing and its possible impact on mucosal immune responses. Ageing Res. Rev. 9, 101-106 (2010).
22. Holmgren J, Czerkinsky C: Mucosal immunity and vaccines. Nat. Med. 11, S45-S53 (2005).
23. Ogra PL, Karzon DT: Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine. J. Immunol. 102, 1423-1430 (1969).
24. Kiyono H, Kunisawa J, McGhee JR, Mestecky J: The mucosal immune system. In: Fundamental Immunology (5th Edition). Paul WE (Ed.). Lippincott Williams & Wilkins, Philadelphia, PA, USA 983-1030 (2008).
25. Brandtzaeg P: Mucosal adaptive immunity: impact of exogenous stimuli and feeding. Presented at: Euroconference: Nutrition, Immune Functions and Health. Paris, France, 9-10 June 2005.
26. Cornes JS: Number, size and distribution of Peyer's patches in the human small intestine. Part 1. The development of Peyer's patches. Gut 6, 225-233 (1965).
27. MacDonald TT, Spencer J: Ontogeny of the gut-associated lymphoid system in man. Acta Paediatr. Suppl. 83, 3-5 (1994).
28. Cripps AW, Gleeson M: Ontogeny of mucosal immunity and aging. In: Mucosal Immunology (3rd Edition). Mestecky J, Lamm M, McGhee J, Bienenstock J, Mayer L, Strober W (Eds). Elsevier Academic Press, NY, USA (2005).
29. Kiyono H, Fukuyama S: NALT-versus Peyer's patch-mediated mucosal immunity. Nat. Rev. 4, 699-710 (2004).
30. Kunisawa J, Nochi T, Kiyono H: Immunological commonalities and distinctions between airway and digestive immunity. Trends Immunol. 29, 505-513 (2008).
31. Adkins B, Leclerc C, Marshall-Clarke S: Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4, 553 (2004).
32. Lewis DB, Wilson CB: Developmental immunology and role of host defenses in fetal and neonatal susceptibility to infection. In: Infectious Diseases of the Fetus and Newborn Infant, (6th Edition). Remington J, Klein J, Wilson C, Baker C (Eds). Elsevier-Saunders, PA, USA, 87-210 (2006).
33. Li L, Lee HH, Bell JJ et al.: IL-4 utilizes an alternative receptor to drive apoptosis of Th1 cells and skews neonatal immunity toward Th2. Immunity 20, 429-440 (2004).
34. Holt PG: Functionally mature virus-specific CD8+ T memory cells in congenitally infected newborns: proof of principle for neonatal vaccination? J. Clin Invest. 111, 1645-1647 (2003).
35. Zaghouani H, Hoeman CM, Adkins B: Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol. 30, 585-591 (2009).
36. Wilson CB, Kollmann TR: Induction of antigen-specific immunity in human neonates and infants. In: The Window of Opportunity: Pre-Pregnancy to 24 Months of Age. Nestle Nutrition Workshop. Barker D, Bergman R, Ogra PL (Eds). Karger AG, Basel, Switzerland 61, 183-196 (2008).
37. Tannock GW: Normal Microflora. Chapman & Hall, London, UK, 1-60 (1995).
38. Margulis L, Sagan D, Thomas L: Microcosmos: Four Billion Years of Evolution from Our Microbial Ancestors. University of California Press, CA, USA (1997).
39. Stark PL, Lee A: The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. J. Med. Microbiol. 15, 189-203 (1982).
40. Vassallo MF, Walker WA. Neonatal microbial flora and disease outcome, In: Window of Opportunity: Pre-pregnancy to 24 Months of Age. Nestle Nutrition Workshop ser. Pediatric Program (Volume 6). Barker DJP, Bergmann RL, Ogra PL (Eds). Nestle Ltd. Vevey/S Karger AG, Basel, Switzerland, 211-224 (2008)
41. Savage DC: Microbial ecology of the gastrointestinal tract. Ann. Rev. Microbiol. 31, 107-133 (1997).
42. Ogra PL, Rassin DK, Garofalo RP: Human milk. In: Infectious Diseases of the Fetus and Newborn Infant, (6th Edition). Remington J, Klein J, Wilson C, Baker C (Eds). Elsevier-Saunders, PA, USA 211-243 (2006).
43. Hooper LV, Gordon J: Commensal host-bacterial relationships in the gut. Science 292, 115-118 (2001).
44. Sudo N, Sawanura S-A, Tanaka K et al.: The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159, 1739-1745 (1997).
45. Adlerberth I, Hansson LA, Wold AE: The ontogeny of the intestinal flora. In: Development of the Gastrointestinal Tract. Sanderson IR, Walker WA (Eds). Decker, OH, USA, 279-292 (1999).
46. Alderberth I, Lindberg E, Aberg N et al.: Reduced enterobacterial and increased Staphylococcal colonization of the infantile bowel: an effect of hygienic lifestyle? Paediatr. Res. 59, 96-101 (2006).
47. Faden H: The microbiologic and immunologic basis for recurrent otitis media in children. Eur. J. Pediatr. 160, 407-413 (2001).
48. Rayco-Solon P, Moore SE, Fulford AJ, Frentice AM: Fifty-year mortality trends in three rural African villages. Trop. Med. Int. Health 9, 1151-1160 (2004).
49. Moore SE, Jalil F, Ashraf F et al.: Birth weight predicts response to vaccination in adults born in an urban slum in Lahore, Pakistan. Am. J. Clin. Nutr. 80, 453-459 (2004).
50. Rhee KJ, Jasper PJ, Sethupathi P, Shanmugam M, Lanning D, Knight KL: Positive selection of the peripheral B cell repertoire in gut-associated lymphoid tissues. J. Exp. Med. 201, 55-62 (2005).
51. Severson KM, Mallozzi M, Driks A, Knight KL: B cell development in GALT: role of bacterial superantigen-like molecules. J. Immunol. 184, 6782-6789 (2010).